Purchase Order 36C24922P0477
- Not listed
- This is a $1,799,245.83 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and related medical products. The contract is for the delivery of unspecified REAGENTS with an ultimate completion date of August 10, 2024. Roche Diagnostics is an experienced federal contractor, holding multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across...
- This is a $38,021.42 firm fixed-price delivery order awarded by the Plains Area of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory instruments. The contract is for COBAS E411 and INTEGRA 400 PLUS service agreements, which provides maintenance and support for these specialized clinical chemistry and immunochemistry analyzers used in VA medical facilities. This delivery order is part of...
- This is a $400,033 firm fixed price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of medical diagnostic products and equipment. The contract is for the delivery of reagents, with a period of performance through August 10, 2025. Roche Diagnostics has previously received other prime and subcontract awards from the VA, Department of Defense,...
- This is a $181,236.02 Firm Fixed Price contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and medical laboratory equipment. The contract is a Blanket Purchase Agreement (BPA) call under the Critical Analyzers, Laboratory (FSS-66-III) schedule, enabling the VA to efficiently acquire Roche's medical diagnostic technologies and services. The contract is for the provision of a VCB Immunoassay/Chemistry...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $332,967.55 firm fixed-price delivery order, which does not have a set-aside designation, is for the provision of chemical analyzers under the Critical Analyzers, Laboratory schedule (FSS-66-III) of the General Services...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $875,220.60, is a Firm Fixed Price Delivery Order awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9. The contract is not set aside and will run through September 30, 2023. Roche Diagnostics is a global...
- This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $100,656.28 firm-fixed-price purchase order is for laboratory equipment and consumables, with a completion date of September 30, 2022. No set-aside designation was used. Roche Diagnostics has a strong track record of...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, with a ceiling value of $219,274.15, is a Delivery Order under the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 16. It is not designated as a set-aside contract. The contract provides for the delivery of Roche's medical diagnostic...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,691,568.24 contract is a delivery order awarded on December 1, 2018, with a completion date of May 31, 2020. It is a firm-fixed-price...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer and distributor of in vitro diagnostics, to provide maintenance services for a Roche HE 600 analyzer. The $172,500.57 contract was awarded on February 27, 2019, with a completion date of February 21, 2023. Roche Diagnostics has previously received awards from the VA, Department of Defense, Department of Health...
This is a $311,081.10 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 9 of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products and laboratory instruments. The contract is for the provision of an ANALYZER and has an ultimate completion date of April 19, 2027. The award is not associated with a set-aside program. Roche Diagnostics holds multiple Indefinite Delivery Vehicles and Blanket Purchase Agreements with various federal agencies, including a $37 million BPA with the Defense Health Agency and a $5.5 million BPA with VA's VISN 10 network, for the supply of specialized laboratory equipment, reagents, and testing services. These contract vehicles are primarily established under GSA Schedule contracts for critical analyzers and in vitro diagnostics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Supplemental Agreement for work within scope | $22.6k | 6/12/25 | |
| P00004 | Exercise an Option | $22.6k | 4/20/25 | |
| P00003 | Funding Only Action | $17.0k | 8/21/24 | |
| P00002 | Exercise an Option | $22.6k | 3/20/24 | |
| P00001 | Funding Only Action | $22.6k | 2/8/23 |